ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
Hyloris Pharmaceuticals: ifrs:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss
One fact, its scope and the complete path back to the official record.
Reported value
581.000k{"amount": 581000.0}- Entity
- Hyloris Pharmaceuticals
- Metric
- ifrs:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss
- Period
- 2020-01-01 – 2020-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:875500LZIWS7QEQE0I73:2021-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T01:33:11.575712+02:00
Raw response SHA-256
8f67d6e16c32451649ebb988edb69d79…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.